A Study to Assess the Accuracy of Artificial Intelligence for Ultrasound-guided Regional Anesthesia

NCT05807737 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-04-11

No results posted yet for this study

Summary

The goal of this observational study is to assess the accuracy of Artificial Intelligence (AI) software to assist ultrasound scanning prior to peripheral nerve blocks. 40 healthy volunteers are going to be accepted to this study in which ultrasound scanning will be performed for four different block types.

The main questions it aims to answer are:

* Can Nerveblox, the artificial intelligence software highlight and find the key anatomical landmarks on the provided nerve or plane block correctly?
* Can the user obtain a correct view of provided nerve or plane block, when the AI software scan success reaches 100%?

Participants will be evaluated under four nerve block regions to identify their key anatomical landmarks using ultrasound-guided artificial intelligence software.

Three residents with different levels of Ultrasound-guided Regional Anesthesia(UGRA) experience but eligible to perform UGRA techniques will collect the ultrasound images when the artificial intelligence software scan success fed by ultrasound reached 100%. After collecting US images, each pair of US images(highlighted and raw ) will be evaluated by 2 experts for the accuracy of AI assistance, independently and blindly.

Conditions

  • Ultrasound Imaging

Interventions

DEVICE

Ultrasound scanning with artificial intelligence

Three residents who are eligible to perform ultrasound-guided regional anesthesia will scan volunteers in random order with artificial intelligence software (Nerveblox) fed by an FDA-cleared ultrasound device.

Sponsors & Collaborators

  • Gazi University

    collaborator OTHER
  • Smart Alfa Teknoloji San. ve Tic. A.S.

    lead INDUSTRY

Principal Investigators

  • Dudu Berrin Günaydın, Proffessor · Gazi University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2020-11-15
Completion
2020-11-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05807737 on ClinicalTrials.gov